A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants
Clinical trial NCT07204418 · RECRUITING
Trial details
- NCT number
- NCT07204418
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-13
- Primary completion
- 2026-12-03
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.